Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2025.04.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Hakan Ozturk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gazi University, Pediatric Gastroenterology, Hepatology, and Nutrition, Ankara, Turkey. Electronic address: hakan.ozturk@gazi.edu.tr. Hauptthemen laut MEDLINE: Portal Vein, Hypertension, Portal, Liver Cirrhosis, Venous Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Portal vein thrombosis (PVT) has been increasingly diagnosed in pediatric patients owing to the widespread use of non-invasive radiological techniques. Although the prevalence of PVT in adults with cirrhosis and intrahepatic non-cirrhotic portal hypertension ranges from 0.6 to 26 % and 13 to 46 %, respectively, no available data exist in the pediatric population. The prevalence of PVT in children with cirrhotic and intrahepatic non-cirrhotic portal hypertension was evaluated in this study. METHODS: This retrospective study included children with cirrhosis and intrahepatic non-cirrhotic portal hypertension, which consisted of congenital hepatic fibrosis (CHF) and idiopathic noncirrhotic portal hypertension (INCPH). Patients with extrahepatic portal venous obstruction were excluded from the study. The presence of PVT was evaluated using abdominal Doppler ultrasonography and/or CT. Etiological, clinical, and laboratory findings were compared between the groups. RESULTS: One hundred and forty-two patients with cirrhosis (mean admission age: 64.6 months ± 66.4, mean follow-up duration: 46.8 months ± 45.6) and 41 patients with non-cirrhotic patients (CHF=16, INCPH = 25, mean admission age: 126 months ± 64.2) were enrolled in this study. The prevalence of PVT was not significantly different between cirrhotic (8.5 %) and non-cirrhotic (9.7 %) patients. The incidence of PVT was significantly higher in patients with biliary atresia than in those with other etiologies in the cirrhotic group (p = 0.022). The frequency of PVT was higher in patients who had Child-Pugh score ≥7 in the cirrhotic group, but the difference was not statistically significant (p = 0066). The PVT group required more liver transplantations than the non-PVT group (p = 0.038). CONCLUSION: The prevalence of PVT was similar in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension in our cohort, which is compatible with adult studies. Biliary atresia is found to be an important risk factor for PVT in our pediatric population. It might be associated with rapid progression of the disease, ascending cholangitis, and embryological abnormalities. These patients should be routinely evaluated to identify portal vein complications and early warning signs during follow-up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gazi University, Pediatric Gastroenterology, Hepatology, and Nutrition, Ankara, Turkey. Electronic address: hakan.ozturk@gazi.edu.tr.
- Gazi University, Pediatric Gastroenterology, Hepatology, and Nutrition, Ankara, Turkey.
Zitieren
APA
Ozturk, H., Sari, S., Gurkan, O. E., & Dalgic, B. (2025). Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2025.04.038
Vancouver
Ozturk H, Sari S, Gurkan OE, Dalgic B. Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2025.04.038
BibTeX
@article{Ozturk2025,
author = {Ozturk, Hakan and Sari, Sinan and Gurkan, Odul Egritas and Dalgic, Buket},
title = {Prevalence of portal vein thrombosis in pediatric patients with cirrhosis and intrahepatic non-cirrhotic portal hypertension},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2025.04.038}
}
EUVIMED